Search Results for: Merck

Merck boost for antibody design startup

Posted on June 9, 2024

Israel’s Biolojic Design (see here previously) is partnering Merck, to develop molecules that could be the basis for therapies to treat cancer and other immunological disorders. The venture is potentially worth up to 350 million euros to the Israeli company. … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment

Merck partners Israeli toxicity predictor

Posted on October 22, 2023

Israel’s Quris-AI (see here previously), which uses AI to predict treatment toxicity, has extended its partnership with German giant Merck KGaA. Quris-AI cuts the cost of treatment development and avoids testing on animals. https://www.calcalistech.com/ctechnews/article/b1repomxp

Posted in Economy & Business | Leave a comment

Merck to test new treatments using Israeli chips

Posted on February 13, 2022

Global giant Merck has signed an agreement worth many millions of dollars with Israel’s Quris (see here previously). Merck will be able to use the Quris “human on a chip” platform to test its new medicines and identify those that … Continue reading →

Posted in Economy & Business | Leave a comment

Merck’s latest Israeli venture

Posted on February 23, 2019

I’ve reported previously (see here) on Germany’s Merck and its many Israeli links. Merck’s VC arm M Ventures has just launched another startup incubator PMatX.  It will support Israeli companies specializing in advanced electronic products including semiconductors and sensor technologies. … Continue reading →

Posted in Economy & Business | Leave a comment

Merck partners Israeli meds tracker

Posted on April 30, 2018

I reported previously (see here) on Israel’s MediSafe’s and its medication tracker app. Now the medical giant Merck KGaA is to work with MediSafe to develop a custom version of its mobile application for tracking treatment of cardiometabolic conditions. https://www.calcalistech.com/ctech/articles/0,7340,L-3735265,00.html

Posted in Israel's Medical Achievements | Leave a comment

Merck’s 3rd biotech incubator

Posted on February 27, 2018

The Merck Group and Shanghai’s WuXi AppTec have launched the biotech startup incubator ExploreBio. It is Merck’s 3rd Israeli biotech incubator, based at Merck’s existing complex in Yavne and will focus on early stage biotechnology startups. The program has a … Continue reading →

Posted in Economy & Business | Leave a comment

Half of Merck healthcare revenue is due to Israel

Posted on February 12, 2018

Kai Beckmann, CEO of Performance Materials at German giant Merck, stated that Israeli innovation is behind almost half of Merck’s healthcare revenues. Merck has just opened a new technology innovation laboratory at its subsidiary, Qlight Nanotech in Jerusalem. https://www.timesofisrael.com/israel-innovation-makes-up-half-of-merck-healthcare-revenue-top-official-says/

Posted in Economy & Business | Leave a comment

Merck launches Israel electronics incubator

Posted on September 10, 2017

German life-science giant Merck is founding a technological innovation laboratory in Yavne, called PMatX that will function as an incubator for Israeli startups. Its investments will total €20 million and will focus on next-generation electronics. http://www.globes.co.il/en/article-merck-launches-20m-israel-incubator-1001202431

Posted in Economy & Business | Leave a comment

Merck and Weizmann sign medical agreement

Posted on March 6, 2016

US giant Merck has signed a new framework agreement with Israel’s Weizmann Institute to research new solutions in the area of biotechnology and cancer research. Merck has more than 300 employees at four sites throughout Israel. http://www.timesofisrael.com/merck-weizmann-institute-sign-strategic-deal-on-cancer-research/

Posted in Israel's Medical Achievements | Leave a comment

Merck buys Israeli cancer biotech

Posted on August 2, 2015

Germany’s Merck will acquire cCAM Biotherapeutics, the Israeli developer of cancer immunotherapies, for an estimated $600 million. cCAM is developing CM-24, for the treatment of melanoma and certain lung, bladder, gastric, colorectal and ovarian cancers. http://www.haaretz.com/business/1.668381

Posted in Economy & Business | Leave a comment